Excited like a kid at Christmas for Monday, Monday to come. Oh wait, it is Christmas. Two questions: How significant is it for the FDA to grant open label extension as a Phase 3 trial nears its unblinding ? Has any other COVID-19 therapeutic candidate been granted thisc FDA guidance?